BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:--//RIT Events Calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:143711@events.rit.edu
DTSTAMP:20241001T124401Z
SUMMARY:Biomedical and Chemical Engineering Seminar
DTSTART:20241017T163000Z
DTEND:20241017T173000Z
LOCATION:Institute Hall: 1140
DESCRIPTION:<p><strong>Treating Alzheimer’s Disease: Bridging scales
 from Angstroms to Micron</strong></p>
 <p><strong>Dr. Shikha Nangia</strong></p>
 <p><strong>Professor and Interim Department Chair, Biomedical and
 Chemical Engineering</strong></p>
 <p><strong>Syracuse University</strong></p>
 <p>Finding pathways across biological barriers for delivering life-saving
 drugs is entering a new era with the rapid advancement of computational
 resources. My research group focuses on developing simulation methods to
 elucidate the interfacial phenomenon associated with biological barriers
 that play a role in life-threatening diseases such as Alzheimer’s,
 cancer, and chronic infections. Our goal is to influence this
 experimentally dominated research field by providing mechanistic,
 structural, and molecular insights into the barrier functions that were
 computationally unattainable before our work. In the past few years, we
 have made breakthroughs in understanding the molecular architecture of
 the blood-brain barrier and developed strategies to enhance the
 barrier’s permeability for treating neurodegenerative diseases. In my
 talk, I will elaborate on the computational methods we have developed to
 investigate the blood-brain barrier and provide a perspective on treating
 Alzheimer’s disease.</p>
 <p><strong>Bio:</strong></p>
 <p>Shikha Nangia, PhD, is a Professor and Interim Chair of the Department
 of Biomedical and Chemical Engineering at Syracuse University. Dr. Nangia
 received her PhD in Chemistry from the University of Minnesota, Twin
 Cities, in 2006 and completed her postdoctoral training at Pennsylvania
 State University. Dr. Nangia’s research uses computational approaches
 to overcome biological barriers and enhance drug delivery. Her research
 projects include exploring treatments for Alzheimer’s and Parkinson’s
 diseases, gut tight junctions, implantable device-related infections, and
 epigenetics. Her focus has been to examine the architecture of the
 blood-brain barrier to develop novel strategies to facilitate the
 transport of drug molecules into the brain. Dr Nangia’s research has
 received substantial funding to date. Dr Nangia has also received
 numerous honors and awards for her research (NSF CAREER, Scialog Fellow,
 ACS OpenEye Faculty Award, ACS WCC Rising Star Award) and teaching
 throughout her career. She was recognized with the Chancellor’s Award
 for her outstanding contribution to the student experience and university
 initiatives at Syracuse University. She is a director of the NIH-funded
 ESTEEMED program that prepares undergraduate students for a career as a
 Ph.D.-level biomedical researcher.</p>
END:VEVENT
END:VCALENDAR
